# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001731122-25-000609
Filing Date
2025-04-25
Accepted
2025-04-25 16:35:45
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM DEFA14A | e6535_defa14a.htm | DEFA14A | 7558
2 | GRAPHIC | p_001.jpg | GRAPHIC | 783751
3 | GRAPHIC | p_002.jpg | GRAPHIC | 438834
| Complete submission text file | 0001731122-25-000609.txt |  | 1692679

Mailing Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111
Business Address 630 5TH AVENUE 20TH FLOOR NEW YORK NY 10111 844-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

EIN.: 980608404 | Fiscal Year End: 0930
Type: DEFA14A | Act: 34 | File No.: 001-37606 | Film No.: 25874733
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)